Cochrane Abstracts
Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Metal Protein Attenuating Compounds for the Treatment of Alzheimer's Dementia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439198/all/Metal_protein_attenuating_compounds_for_the_treatment_of_Alzheimer&apos.
Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439198/all/Metal_protein_attenuating_compounds_for_the_treatment_of_Alzheimer&apos. Accessed February 8, 2026.
Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439198/all/Metal_protein_attenuating_compounds_for_the_treatment_of_Alzheimer&apos
Metal Protein Attenuating Compounds for the Treatment of Alzheimer's Dementia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439198/all/Metal_protein_attenuating_compounds_for_the_treatment_of_Alzheimer&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review
ID - 439198
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439198/all/Metal_protein_attenuating_compounds_for_the_treatment_of_Alzheimer&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
